Giving More Options to Patients With DCIS
Data from clinical trials presented at SABCS may help patients with DCIS make informed choices between different management strategies.
Progress Against Cancer
Data from clinical trials presented at SABCS may help patients with DCIS make informed choices between different management strategies.
As we head into the holiday season, Cancer Research Catalyst has tantalizing teasers in the form of science stocking stuffers straight from our November edition of Editors’ Picks. This month, the editors of the...
Using high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
New research into potential causes of gastric cancer is looking beyond H. pylori to other bacteria within the gastric microbiome.
Recent advances in EGFR inhibition include combinations to overcome resistance and approvals for newly diagnosed or early-stage lung cancers.
This month, the editors selected studies comparing CAR T therapies for large B-cell lymphoma, assessing a new type of blood test for colorectal cancer detection, and more.
Treating seemingly inoperable liver tumors with neoadjuvant immunotherapy may make surgery more feasible.
This month, AACR's journals editors highlighted factors that may reduce pancreatic cancer risk, a new humanized mouse model, and more.
August’s edition of Editors’ Picks includes biomarkers of immunotherapy response, individualized colorectal screening guidelines, and other exciting research.
New cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening and monitoring.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More